Article
Dermatologists aren't the only ones who see the virtues of Accutane (isotretinoin).
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Upadacitinib Induces Long-Term Remission in Refractory Bullous Pemphigoid: A Case Report
Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness
Social Media Significantly Influences Attitudes, Behaviors Toward Skin Health
Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
Daily Derm Times: June 18, 2025
Both Upadacitinib and Abrocitinib Demonstrate Real-World Efficacy in AD Patients After 1 Year